133 related articles for article (PubMed ID: 28735213)
1. Chemoselective synthesis and biological evaluation of arylated 2-(Trifluoromethyl) quinolines as nucleotide pyrophosphatase (NPPs) inhibitors.
Kuhrt D; Ejaz SA; Afzal S; Khan SU; Lecka J; Sévigny J; Ehlers P; Spannenberg A; Iqbal J; Langer P
Eur J Med Chem; 2017 Sep; 138():816-829. PubMed ID: 28735213
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
4. Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies.
Hayat K; Afzal S; Saeed A; Murtaza A; Ur Rahman S; Khan KM; Saeed A; Zaib S; Lecka J; Sévigny J; Iqbal J; Hassan A
Bioorg Chem; 2019 Jun; 87():218-226. PubMed ID: 30903944
[TBL] [Abstract][Full Text] [Related]
5. Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Channar PA; Afzal S; Ejaz SA; Saeed A; Larik FA; Mahesar PA; Lecka J; Sévigny J; Erben MF; Iqbal J
Eur J Med Chem; 2018 Aug; 156():461-478. PubMed ID: 30015078
[TBL] [Abstract][Full Text] [Related]
6. Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines.
Llona-Minguez S; Häggblad M; Martens U; Throup A; Loseva O; Jemth AS; Lundgren B; Scobie M; Helleday T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3897-3904. PubMed ID: 28687206
[TBL] [Abstract][Full Text] [Related]
7. Divergent synthesis and elaboration of structure activity relationship for quinoline derivatives as highly selective NTPDase inhibitor.
Murtaza A; Afzal S; Zaman G; Saeed A; Pelletier J; Sévigny J; Iqbal J; Hassan A
Bioorg Chem; 2021 Oct; 115():105240. PubMed ID: 34416508
[TBL] [Abstract][Full Text] [Related]
8. New one-pot synthesis of N-fused isoquinoline derivatives by palladium-catalyzed C-H arylation: potent inhibitors of nucleotide pyrophosphatase-1 and -3.
Ausekle E; Ejaz SA; Khan SU; Ehlers P; Villinger A; Lecka J; Sévigny J; Iqbal J; Langer P
Org Biomol Chem; 2016 Dec; 14(48):11402-11414. PubMed ID: 27858054
[TBL] [Abstract][Full Text] [Related]
9. Ecto-nucleotidase inhibitors: recent developments in drug discovery.
Baqi Y
Mini Rev Med Chem; 2015; 15(1):21-33. PubMed ID: 25694081
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1.
Forcellini E; Boutin S; Lefebvre CA; Shayhidin EE; Boulanger MC; Rhéaume G; Barbeau X; Lagüe P; Mathieu P; Paquin JF
Eur J Med Chem; 2018 Mar; 147():130-149. PubMed ID: 29427906
[TBL] [Abstract][Full Text] [Related]
12. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, functionalization and biological activity of arylated derivatives of (+)-estrone.
Ivanov A; Ejaz SA; Shah SJA; Ehlers P; Villinger A; Frank E; Schneider G; Wölfling J; Rahman Q; Iqbal J; Langer P
Bioorg Med Chem; 2017 Feb; 25(3):949-962. PubMed ID: 28034648
[TBL] [Abstract][Full Text] [Related]
14. Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?
Roszek K; Czarnecka J
Mini Rev Med Chem; 2015; 15(1):5-20. PubMed ID: 25694082
[TBL] [Abstract][Full Text] [Related]
15. 2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.
Jafari B; Ospanov M; Ejaz SA; Yelibayeva N; Khan SU; Amjad ST; Safarov S; Abilov ZA; Turmukhanova MZ; Kalugin SN; Ehlers P; Lecka J; Sévigny J; Iqbal J; Langer P
Eur J Med Chem; 2018 Jan; 144():116-127. PubMed ID: 29268128
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of thiadiazole amide derivatives as nucleoside triphosphate diphosphohydrolases (NTPDases) inhibitors.
Abbas S; Afzal S; Nadeem H; Hussain D; Langer P; Sévigny J; Ashraf Z; Iqbal J
Bioorg Chem; 2022 Jan; 118():105456. PubMed ID: 34800887
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Structural Characterization and Antinociceptive Activities of New Arylated Quinolines via Suzuki-Miyaura Cross Coupling Reaction.
Ullah MA; Adeel M; Tahir MN; Rauf A; Akram M; Hadda TB; Mabkhot YN; Muhammad N; Naseer F; Mubarak MS
Med Chem; 2017; 13(8):780-786. PubMed ID: 28676003
[TBL] [Abstract][Full Text] [Related]
19. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
